Your search for

71 results were returned

  1. Legal news
    11 February 2021
    Patent Linkage Update in China - A Pre-Chinese New Year Gift
    www.twobirds.com/en/news/articles/2021/china/patent-linkage-update-in-china-a-prechinese-new-year-gift

    On 9 February 2021, the China National Intellectual Property Administration (“CNIPA”) issued the “Administrative Adjudication Measures for Drug Patent Dispute Early Resolution Mechanism (Draft for Public Opinions)” ...

  2. Legal news
    29 April 2021
    London & the life sciences
    www.twobirds.com/en/news/articles/2021/uk/london-and-the-life-sciences

    Europe’s biotech industry is more buoyant now than it’s ever been. A combination of eager investors, the high-speed development of COVID-19 vaccines, exciting scientific developments and last year’s acceleration of ...

  3. Legal news
    30 September 2019
    Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
    www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

    On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...

  4. Legal news
    03 September 2019
    China Expands Medical Devices Market Authorization Holder Pilot Project to 21 Provinces/Municipalities
    www.twobirds.com/en/news/articles/2019/global/china-expands-medical-devices-market-authorization-holder-pilot-project-to-21-provinces

    On 1 August 2019, the National Medical Products Administration ("NMPA") issued a notice to extend the pilot project of medical device registrant system (GUO YAO JIAN XIE ZHU (2019) No.33) ("Notice") to 21 ...

  5. Legal news
    20 June 2019
    China to accelerate the development of "Smart Supervision System" for drug and medical devices
    www.twobirds.com/en/news/articles/2019/global/china-to-accelerate-the-development-of-smart-supervision-system-for-drug-and-medical-devices

    The NMPA issued the Drug Smart Supervision Plan aiming to deepen the development of a drug supervision system embracing modern information technologies such as cloud computing, big data, and "Internet+" technologies.

  6. Legal news
    06 September 2019
    China passed new amendments to the Drug Administration Law
    www.twobirds.com/en/news/articles/2019/global/china-passed-new-amendments-to-the-drug-administration-law

    On 26 August 2019, China's National People's Congress passed the final amendments to the Drug Administration Law ("DAL"), which will take effect on 1 December 2019. The DAL was first enacted in 1984, then substantively ...

  7. Legal news
    03 April 2019
    Patents: possible defence to infringement by equivalence
    www.twobirds.com/en/news/articles/2019/global/patents-possible-defence-to-infringement-by-equivalence

    The Intellectual Property Enterprise Court (IPEC) has held that a patent was invalid but also considered a possible defence to infringement by equivalence.

  8. Legal news
    16 November 2017
    Actavis v ICOS– No interim injunction pending Supreme Court appeal
    www.twobirds.com/en/news/articles/2017/global/actavis-v-icos-no-interim-injunction-pending-supreme-court-appeal

    On 10 November 2017, Henry Carr J in the English Patents Court delivered a significant decision which will be of great interest to litigants in the field of generic pharmaceuticals.

  9. Legal news
    07 December 2017
    Equivalents Unchained
    www.twobirds.com/en/news/articles/2017/global/equivalents-unchained

    The Actavis v Eli Lilly decision of the UK Supreme Court has been described by some commentators as being a minor gloss on the law of patent infringement and claim scope.

  10. Legal news
    24 July 2017
    New Polish Restrictions on Pharmacy Ownership
    www.twobirds.com/en/news/articles/2017/poland/new-polish-restrictions-on-pharmacy-ownership

    Operating and establishing pharmacies has long been subject to strict regulations in Poland, for example anti-concentration requirements and the ban on advertising pharmacies.